Perinatal exposure to low-dose 2,2′,4,4′-tetrabromodiphenyl ether affects growth in rat offspring: What is the role of IGF-1?

Toxicology

Volumn 260, Issue 1-3, 2009, Pages 126-131

  Suvorov, Alexander ^a   Battista, Marie Claude ^a   Takser, Larissa ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Endocrine disruptor; Fetal programming; IGF 1; Low dose; PBDE; Rat

Indexed keywords

2,2',4,4' TETRABROMODIPHENYL ETHER; ETHER DERIVATIVE; POLYBROMINATED DIPHENYL ETHER; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BODY HEIGHT; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVATION; FEMALE; FETUS; GESTATIONAL AGE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; MALE; NEWBORN; NONHUMAN; OUTCOME ASSESSMENT; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROGENY; RAT; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; BIRTH WEIGHT; BODY WEIGHT; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; GROWTH; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; LITTER SIZE; MATERNAL EXPOSURE; POLYBROMINATED BIPHENYLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEX FACTORS;

RATTUS;

EID: 67349112685     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.03.018     Document Type: Article

References (51)

1. Ackland F.M., and Preece M.A. Catch-up growth. Pediatrician 14 (1987) 226-233
2. Albertsson-Wikland K., Rosberg S., Libre E., Lundberg L.O., and Groth T. Growth hormone secretory rates in children as estimated by deconvolution analysis of 24-h plasma concentration profiles. Am. J. Physiol. 257 (1989) E809-E814
3. Barker D.J. Intrauterine programming of adult disease. Mol. Med. Today 1 (1995) 418-423
4. Bellantoni M.F., Vittone J., Campfield A.T., Bass K.M., Harman S.M., and Blackman M.R. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. J. Clin. Endocrinol. Metab. 81 (1996) 2848-2853
5. Birnbaum L.S., and Staskal D.F. Brominated flame retardants: cause for concern?. Environ. Health Perspect. 112 (2004) 9-17
6. Borski R.J., Tsai W., DeMott-Friberg R., and Barkan A.L. Regulation of somatic growth and the somatotropic axis by gonadal steroids: primary effect on insulin-like growth factor I gene expression and secretion. Endocrinology 137 (1996) 3253-3259
7. Breslin W.J., Kirk H.D., and Zimmer M.A. Teratogenic evaluation of a polybromodiphenyl oxide mixture in New Zealand white rabbits following oral exposure. Fundam. Appl. Toxicol. 12 (1989) 151-157
8. Ceccatelli R., Faass O., Schlumpf M., and Lichtensteiger W. Gene expression and estrogen sensitivity in rat uterus after developmental exposure to the polybrominated diphenylether PBDE 99 and PCB. Toxicology 220 (2006) 104-116
9. Chowen J.A., Frago L.M., and Argente J. The regulation of GH secretion by sex steroids. Eur. J. Endocrinol. 151 Suppl. 3 (2004) U95-U100
10. Darnerud P.O. Brominated flame retardants as possible endocrine disrupters. Int. J. Androl. 31 (2008) 152-160
11. Delemarre-van de Waal H.A., van Coeverden S.C., and Rotteveel J. Hormonal determinants of pubertal growth. J. Pediatr. Endocrinol. Metab. 14 Suppl. 6 (2001) 1521-1526
12. Druet C., and Ong K.K. Early childhood predictors of adult body composition. Best Pract. Res. Clin. Endocrinol. Metab. 22 (2008) 489-502
13. Fernie K.J., Laird Shutt J., Ritchie I.J., Letcher R.J., Drouillard K., and Bird D.M. Changes in the growth, but not the survival, of American kestrels (Falco sparverius) exposed to environmentally relevant polybrominated diphenyl ethers. J. Toxicol. Environ. Health A 69 (2006) 1541-1554
14. Fischer D., Hooper K., Athanasiadou M., Athanassiadis I., and Bergman A. Children show highest levels of polybrominated diphenyl ethers in a California family of four: a case study. Environ. Health Perspect. 114 (2006) 1581-1584
15. Friend K.E., Hartman M.L., Pezzoli S.S., Clasey J.L., and Thorner M.O. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women-a clinical research center study. J. Clin. Endocrinol. Metab. 81 (1996) 2250-2256
16. Gee J.R., and Moser V.C. Acute postnatal exposure to brominated diphenylether 47 delays neuromotor ontogeny and alters motor activity in mice. Neurotoxicol. Teratol. 30 (2008) 79-87
17. Giustina A., Scalvini T., Tassi C., Desenzani P., Poiesi C., Wehrenberg W.B., Rogol A.D., and Veldhuis J.D. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J. Clin. Endocrinol. Metab. 82 (1997) 1210-1219
18. Guvenius D.M., Aronsson A., Ekman-Ordeberg G., Bergman A., and Noren K. Human prenatal and postnatal exposure to polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenylols, and pentachlorophenol. Environ. Health Perspect. 111 (2003) 1235-1241
19. Hites R.A. Polybrominated diphenyl ethers in the environment and in people: a meta-analysis of concentrations. Environ. Sci. Technol. 38 (2004) 945-956
20. Hoffman A.R. Treatment of the adult growth hormone deficiency syndrome: directions for future research. Growth Horm. IGF Res. 15 Suppl. A (2005) 48-52
21. Huhtaniemi I. Fetal testis-a very special endocrine organ. Eur. J. Endocrinol. 130 (1994) 25-31
22. Huwe J., Hakk H., and Lorentzsen M. Bioavailability and mass balance studies of a commercial pentabromodiphenyl ether mixture in male Sprague-Dawley rats. Chemosphere 66 (2007) 259-266
23. IPCS. Environmental Health Criteria No. 152: Polybrominated Biphenyls (1994), World Health Organisation, Geneva
24. IPCS. Environmental Health Criteria No. 162: Brominated Diphenyl ethers (1994), World Health Organisation, Geneva
25. Johnson-Restrepo B., Kannan K., Rapaport D.P., and Rodan B.D. Polybrominated diphenyl ethers and polychlorinated biphenyls in human adipose tissue from New York. Environ. Sci. Technol. 39 (2005) 5177-5182
26. Keenan B.S., Richards G.E., Ponder S.W., Dallas J.S., Nagamani M., and Smith E.R. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J. Clin. Endocrinol. Metab. 76 (1993) 996-1001
27. Kerrigan J.R., and Rogol A.D. The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. Endocr. Rev. 13 (1992) 281-298
28. Kuriyama S.N., Wanner A., Fidalgo-Neto A.A., Talsness C.E., Koerner W., and Chahoud I. Developmental exposure to low-dose PBDE-99: tissue distribution and thyroid hormone levels. Toxicology 242 (2007) 80-90
29. LeRoith D., and Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 302-310
30. Leung K.C., Johannsson G., Leong G.M., and Ho K.K. Estrogen regulation of growth hormone action. Endocr. Rev. 25 (2004) 693-721
31. Lin D., Harris R., Stutzman R., Zampighi G.A., Davidson H., and Takemoto D.J. Protein kinase C-gamma activation in the early streptozotocin diabetic rat lens. Curr. Eye Res. 32 (2007) 523-532
32. Liu L., Merriam G.R., and Sherins R.J. Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 64 (1987) 651-656
33. Loche S., Colao A., Cappa M., Bellone J., Aimaretti G., Farello G., Faedda A., Lombardi G., Deghenghi R., and Ghigo E. The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids. J. Clin. Endocrinol. Metab. 82 (1997) 861-864
34. Martins E.B., and Carvalho M.S. Birth weight and overweight in childhood: a systematic review. Cad. Saude Publica 22 (2006) 2281-2300
35. Mauras N., and Haymond M.W. Are the metabolic effects of GH and IGF-I separable?. Growth Horm. IGF Res. 15 (2005) 19-27
36. Mazdai A., Dodder N.G., Abernathy M.P., Hites R.A., and Bigsby R.M. Polybrominated diphenyl ethers in maternal and fetal blood samples. Environ. Health Perspect. 111 (2003) 1249-1252
37. Meinhardt U.J., and Ho K.K. Modulation of growth hormone action by sex steroids. Clin. Endocrinol. (Oxf.) 65 (2006) 413-422
38. Moll Jr. G.W., Rosenfield R.L., and Fang V.S. Administration of low-dose estrogen rapidly and directly stimulates growth hormone production. Am. J. Dis. Child 140 (1986) 124-127
39. Orn U., and Klasson-Wehler E. Metabolism of 2,2′,4,4′-tetrabromodiphenyl ether in rat and mouse. Xenobiotica 28 (1998) 199-211
40. Ross M.G., Desai M., Khorram O., McKnight R.A., Lane R.H., and Torday J. Gestational programming of offspring obesity: a potential contributor to Alzheimer's disease. Curr. Alzheimer Res. 4 (2007) 213-217
41. Scarth J.P. Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression. A review. Xenobiotica 36 (2006) 119-218
42. Schecter A., Papke O., Harris T.R., Tung K.C., Musumba A., Olson J., and Birnbaum L. Polybrominated diphenyl ether (PBDE) levels in an expanded market basket survey of U.S. food and estimated PBDE dietary intake by age and sex. Environ. Health Perspect. 114 (2006) 1515-1520
43. Schecter A., Papke O., Tung K.C., Joseph J., Harris T.R., and Dahlgren J. Polybrominated diphenyl ether flame retardants in the U.S. population: current levels, temporal trends, and comparison with dioxins, dibenzofurans, and polychlorinated biphenyls. J. Occup. Environ. Med. 47 (2005) 199-211
44. Sjodin A., Jones R.S., Focant J.F., Lapeza C., Wang R.Y., McGahee III E.E., Zhang Y., Turner W.E., Slazyk B., Needham L.L., and Patterson Jr. D.G. Retrospective time-trend study of polybrominated diphenyl ether and polybrominated and polychlorinated biphenyl levels in human serum from the United States. Environ. Health Perspect. 112 (2004) 654-658
45. Suvorov A., Girard S., Lachapelle S., Abdelouahab N., Sebire G., and Takser L. Perinatal exposure to low-dose BDE-47, an emergent environmental contaminant. Causes hyperactivity in rat offspring. Neonatology 95 (2008) 203-209
46. Suvorov A., and Takser L. Facing the challenge of data transfer from animal models to humans: the case of persistent organohalogens. Environ. Health Perspect. 7 (2008) 58
47. Talsness C.E., Kuriyama S.N., Sterner-Kock A., Schnitker P., Grande S.W., Shakibaei M., Andrade A., Grote K., and Chahoud I. In utero and lactational exposures to low doses of polybrominated diphenyl ether-47 alter the reproductive system and thyroid gland of female rat offspring. Environ. Health Perspect. 116 (2008) 308-314
48. Weissberger A.J., Ho K.K., and Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72 (1991) 374-381
49. Weniger J.P. Estrogen production by fetal rat gonads. J. Steroid Biochem. Mol. Biol. 44 (1993) 459-462
50. Weniger J.P., Zeis A., and Chouraqui J. Estrogen production by fetal and infantile rat ovaries. Reprod. Nutr. Dev. 33 (1993) 129-136
51. Zhou T., Ross D.G., DeVito M.J., and Crofton K.M. Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats. Toxicol. Sci. 61 (2001) 76-82